Immunome, Inc. (IMNM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Immunome, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.83x | -2.13x | -1.99x | -0.73x | -6.05x | -5.49x |
| P/B Ratio | 2.96x | 3.44x | 1.77x | 1.61x | 3.10x | 2.37x |
| P/S Ratio | 270.32x | 68.88x | 15.15x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 57.4% | 100.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -3084.8% | -3382.4% | -781.4% | 0.0% | 0.0% | 0.0% |
| Net Margin | -3060.0% | -3240.4% | -761.9% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -3042.2% | -1674.1% | -199.7% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 14.69x | 4.08x | 6.63x | 3.09x | 5.82x | 14.12x |
| Quick Ratio | 14.69x | 4.08x | 6.63x | 3.09x | 5.82x | 14.12x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.03x | 0.01x | 0.02x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..